Literature DB >> 1827722

Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light.

N Yamamoto1, S Homma, T W Sery, L A Donoso, J K Hoober.   

Abstract

Peritoneal macrophages treated in vivo with haematoporphyrin derivative (HPD) exhibited significant enhancement of Fc receptor mediated ingestion activity. To examine this process more rigorously, we studied photodynamic activation of macrophages by exposure in vitro of mouse peritoneal cell cultures (containing macrophages and B and T-lymphocytes) to HPD and red fluorescent light. A short (10 s) exposure of peritoneal cells in medium containing 0.03 ng HPD/ml produced the maximal level of ingestion activity of macrophages. A singlet oxygen quencher, DABCO, inhibited the effect of HPD. Photodynamic treatment of macrophages alone did not activate the cells and activation was only observed when macrophages were mixed with photodynamically treated non-adherent cells (B and T-lymphocytes). These results imply that activation of macrophage is a consequence of peroxidation of lymphocyte membrane lipids by photodynamically generated singlet oxygen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827722     DOI: 10.1016/0277-5379(91)90388-t

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

3.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

Review 4.  Stimulation of anti-tumor immunity by photodynamic therapy.

Authors:  Pawel Mroz; Javad T Hashmi; Ying-Ying Huang; Norbert Lange; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2011-01       Impact factor: 4.473

5.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

Review 6.  Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Authors:  Zheng Huang; Heping Xu; Arlen D Meyers; Ali I Musani; Luowei Wang; Randall Tagg; Al B Barqawi; Yang K Chen
Journal:  Technol Cancer Res Treat       Date:  2008-08

7.  Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.

Authors:  S Coutier; L Bezdetnaya; S Marchal; V Melnikova; I Belitchenko; J L Merlin; F Guillemin
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

Review 8.  Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.

Authors:  Razan Alzeibak; Tatiana A Mishchenko; Natalia Y Shilyagina; Irina V Balalaeva; Maria V Vedunova; Dmitri V Krysko
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

Review 9.  Photodynamic Therapy-Current Limitations and Novel Approaches.

Authors:  Gurcan Gunaydin; M Emre Gedik; Seylan Ayan
Journal:  Front Chem       Date:  2021-06-10       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.